C1r Antibodies

Santa Cruz Biotechnology features a diverse variety of C1r monoclonal antibodies for research focused on understanding the complement system and its role in immune responses. C1r monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C1r is a serine protease that plays a crucial role in the activation of the complement cascade, which is essential for opsonization, inflammation, and cell lysis. By cleaving C1s, C1r initiates the classical pathway of complement activation, highlighting its importance in both innate and adaptive immunity. Understanding the function of C1r is vital for elucidating mechanisms of immune regulation and potential therapeutic targets in various diseases. Researchers can utilize C1r monoclonal antibodies to investigate complement cascade activation pathways and their implications in immune responses. C1r monoclonal antibodies enable detailed examination of protein-protein interactions within the complement system. Exploring C1r's role in disease progression and immune regulation can lead to new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for C1r support researchers worldwide in advancing our understanding of complement biology and immune system function.